Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

Historical Holders from Q1 2019 to Q3 2025

Symbol
ARMP on NYSE
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
66,587,586
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
758,321
Holdings value
$2,268,277
% of all portfolios
0%
Number of holders
27
Number of buys
6
Number of sells
-6
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Innoviva, Inc. 83.3% -2.2% $75,990,419 -$11,933,796 55,467,459 -13.6% Innoviva, Inc. 11 Aug 2025

Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 758,321 $2,268,277 +$89,233 $2.98 27
2025 Q2 733,816 $1,394,405 +$8,714 $1.9 28
2025 Q1 740,370 $1,080,988 -$948,266 $1.46 25
2024 Q4 1,388,825 $2,569,389 +$5,735 $1.85 22
2024 Q3 1,383,530 $3,279,033 -$52,091 $2.37 21
2024 Q2 1,404,321 $3,861,965 -$42,264 $2.75 21
2024 Q1 1,419,509 $5,933,830 +$546,585 $4.18 22
2023 Q4 1,288,660 $4,173,419 +$25,707 $3.24 23
2023 Q3 1,281,771 $3,844,909 +$326,706 $3 21
2023 Q2 1,185,412 $1,350,731 -$74,311 $1.14 20
2023 Q1 1,234,381 $2,061,949 -$89,077 $1.67 21
2022 Q4 1,303,324 $1,614,012 -$228,188 $1.24 25
2022 Q3 1,358,062 $5,732,000 +$37,042 $4.22 15
2022 Q2 1,349,314 $5,246,000 -$7,456 $3.88 15
2022 Q1 1,351,550 $6,609,000 +$139,417 $4.89 15
2021 Q4 1,322,160 $7,245,000 +$737,783 $5.48 15
2021 Q3 1,192,207 $4,315,000 +$124,784 $3.62 16
2021 Q2 522,741 $2,074,000 -$184,268 $3.97 15
2021 Q1 1,175,413 $5,620,000 +$1,488,585 $4.79 18
2020 Q4 868,164 $2,590,000 -$12,891 $2.99 12
2020 Q3 874,509 $2,789,000 +$51,390 $3.19 14
2020 Q2 857,627 $3,362,000 +$2,663,431 $3.92 13
2020 Q1 167,481 $520,000 +$44,563 $3.1 10
2019 Q4 162,927 $530,000 +$103,853 $3.26 10
2019 Q3 130,883 $484,000 +$46,115 $3.68 9
2019 Q2 118,107 $474,000 -$162,070 $4.02 8
2019 Q1 157,638 $47,000 +$47,008 $0.2982 1